DATE: August 24th 2016
TIME: 8:00AM PST, 11:00AM EST
Preclinical micro-computed tomography (microCT) imaging systems are utilized across a wide range of applications requiring imaging of small anatomical structures, such as vessels and bones. MicroCT offers superior spatial resolution to many other imaging modalities, and recent research incorporates microCT data with optical and nuclear data to generate multimodality datasets, increasing the understanding of disease. PerkinElmer’s Quantum GX microCT imaging systems delivers high resolution scanning while affording imaging protocols with radiation doses low enough to facilitate longitudinal studies, and scan times fast enough to be truly high throughput. These features have led microCT imaging to be incorporated into many emerging applications and inform on functional as well as anatomical information.
In this webinar, Dr. Rochefort will discuss his group’s efforts in expanding the utilization of microCT imaging beyond typical preclinical models. Through the use of vascular contrast agents, increased investigations in many soft tissue organs are now feasible. Applications in stem cells in an angiogenesis model and genetic models will also be discussed. Chris Damoci’s research has focused on the field of oncology, and he will present recent findings in pancreatic and other cancers.
The Quantum GX microCT imaging system is enabling exciting research developments in many emerging applications. Join us for what is sure to be a thought provoking discussion on current and future states of microCT imaging. Christopher Damoci and Professor Rochefort will also answer your questions following the presentation.